20180823: Confirmation of positivity for NF155, NF186, NF140 and CNTN1 of CIDP patients from Holland.

Objective: Confirmation of IgG positivity towardd NF155, NF186, NF140 and CNTN1 of CIDP samples from Holland.

SAMPLES: 

For NF155: 4, 17, 29, 83 115, 139

For NF140 and NF186: 29, 115, 139

For CNTN1: 99, 122

NF155, NF140, NF186 ICC:

  • HEKs 293 Cells Transfection: 2018.08.14
  • Blocking solution: 5% goat serum in PBS.
  • Patient’s sera diluted 1/100 for IgG with 5% goat serum in PBS.
  • Primary antibody: AF3235 diluted 1/1000.
  • Secondary antibodies: For IgG: GAC 488 (1/1000) + GAH 594 IgG (1/1000)
  • Vectashield mounting medium.

CNTN1 ICC:

  • Blocking solution: Rabbit serum diluted 1/40 in PBS.
  • Patient’s sera diluted 1/100 for IgG with rabbit serum 1/40.
  • Primary antibody: AF904 diluted 1/1000.
  • Secondary antibodies: RAG 488 + RAH 594 IgM (1/1000)
  • Vectashield mounting medium.

RESULTS: All samples were positive except for 29.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.